Biomedical subjects
Publications and source records attributed to Arthur G Lipman.
The American Society of Health-System Pharmacists 2003 annual Midyear Clinical meeting in December 2003 was attended by nearly 18,000 individuals and had increased content and networking opportunities of Pharmacists involved in pain management. Initiatives, awards and services presented and announced at the meeting are described.
Explore the source record for details and available documents.
An open label study of topical lidocaine 5% patches was conducted for myofascial pain management based on the hypothesis that electrical dysfunction is a component of myofascial pain and therefore sodium channel blockade may be useful in managing myofascial pain. The efficacy of topical lidocaine patch therapy for myofascial pain impact of the therapy on associated quality of life were investigated in the one-month trial. Principal outcome measures were Brief Pain Inventory- Short Form for pain intensity and quality of life score changes. Twenty-seven patients with moderate-severe myofascial pain were enrolled. Eighteen had low back pain. Two patients reported complete pain relief and 3 reported a lot of relief. Mean improvements for average pain intensity (7, 14, and 28 days), general activity (7 and 28 days), mood and sleep (7, 14, and 28 days), walking (14 and 28 days), and ability to work, relationships, and enjoyment of life (28 days) were significant (P < 0.05). These results suggest lidocaine patches may be useful in the management of myofascial pain.
Nociceptive and neuropathic types of pain occur in rheumatologic conditions. Most clinicians are familiar with the former, but many are not aware of the prevalence of the latter. The literature reports numerous examples of the occurrence of rheumatologic neuropathic pain, but little has been published on its management. In this article, neuropathic and nociceptive pain in rheumatologic conditions are differentiated and treatment recommendations are discussed. Common rheumatologic conditions and their pathophysiology in relation to pain mechanisms also are described. Pharmacotherapeutic recommendations for the treatment of both types of pain in the common rheumatologic conditions are presented.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Recent reports on research supported by the Agency for Healthcare Research and Quality are summarized. These reports relate to use of aspirin for cardioprotection by patients taking NSAIDs, end of life care for nursing home residents with advanced directives, Cancer Patients' Satisfaction With Primary Care Pain Management, the need for increased medical training about adverse drug events, and dorsal root entry zone lesioning for central neuropathic pain. The research summarized in this report was abstracted from the AHRQ Research Activities.
The hospice movement and palliative care programs have grown over the past quarter century at an astounding rate. Such programs now treat far more than just pain or cancer. Nevertheless, recognition of the critical need for improved cancer pain management was the genesis of modern palliative care. However, even today, many Americans lack ready access to such care. Recently, an increased focus on the need for more and better palliative care has led to important new publications, federal funding initiatives from palliative care research, and explicit recommendations from the National Cancer Policy Board on ways to lessen barriers to palliative care. Some of these potential solutions are discussed.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The ASHP Midyear Clinical meeting continues to be the largest pharmacy meeting in the world. A broad range of topics was presented at hundreds of symposia and posters at the 2001 meeting in New Orleans, Louisiana, in December. Pain management, hospice care, evidence based medicine, safe medication practices and improved drug information services were among the many practice areas addressed and recognized at the meeting.
Explore the source record for details and available documents.
Debate about the place and scientific of complementary and alternative medicine (CAM) has increased markedly in 2002 following the release of the report of the White House Commission on Alternative and Complementary Medicine Policy. Arguments for and against the integration of CAM into mainstream medicine that have been made are discussed. Positions taken by organizations opposed to CAM are described as are arguments to study the place of CAM further.
Explore the source record for details and available documents.
Explore the source record for details and available documents.